Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year.
Kremer JM, Blanco R, Brzosko M, Burgos-Vargas R, Halland AM, Vernon E, Ambs P, Fleischmann R. Kremer JM, et al. Among authors: brzosko m. Arthritis Rheum. 2011 Mar;63(3):609-21. doi: 10.1002/art.30158. Arthritis Rheum. 2011. PMID: 21360490 Free article. Clinical Trial.
The early clinical course of infliximab treatment in rheumatoid arthritis: results from the REMARK observational study.
Westhovens R, van Vollenhoven RF, Boumpas DT, Brzosko M, Svensson K, Bjorneboe O, Meeuwisse CM, Srinivasan S, Gaudin P, Smolen JS, Rahman MU, Nelissen RL, Vastesaeger N. Westhovens R, et al. Among authors: brzosko m. Clin Exp Rheumatol. 2014 May-Jun;32(3):315-23. Epub 2014 Feb 11. Clin Exp Rheumatol. 2014. PMID: 24529163 Clinical Trial.
Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial.
Suh CH, Yoo DH, Berrocal Kasay A, Chalouhi El-Khouri E, Cons Molina FF, Shesternya P, Miranda P, Medina-Rodriguez FG, Wiland P, Jeka S, Chavez-Corrales J, Linde T, Hrycaj P, Abello-Banfi M, Hospodarskyy I, Jaworski J, Piotrowski M, Brzosko M, Krogulec M, Shevchuk S, Calvo A, Andersone D, Park W, Shim SC, Lee SJ, Lee SY. Suh CH, et al. Among authors: brzosko m. BioDrugs. 2019 Feb;33(1):79-91. doi: 10.1007/s40259-018-00331-4. BioDrugs. 2019. PMID: 30719632 Free PMC article. Clinical Trial.
Rheumatoid arthritis epidemiology: a nationwide study in Poland.
Krajewska-Włodarczyk M, Szeląg M, Batko B, Żuber Z, Orleański M, Podwójcic K, Sowiński J, Jopek J, Świderek M, Maluchnik M, Brzosko M, Śmiglewska A, Kwiatkowska B. Krajewska-Włodarczyk M, et al. Among authors: brzosko m. Rheumatol Int. 2024 Jun;44(6):1155-1163. doi: 10.1007/s00296-024-05591-8. Epub 2024 Apr 27. Rheumatol Int. 2024. PMID: 38678142 Free PMC article.
150 results